Activation of MAP kinase p38 is critical for the cell-cycle-controlled suppressor function of regulatory T cells

被引:63
作者
Adler, Henric S.
Kubsch, Sebastian
Graulich, Edith
Ludwig, Stephan
Knop, Juergen
Steinbrink, Kerstin
机构
[1] Univ Mainz, Dept Dermatol, D-55131 Mainz, Germany
[2] Univ Munster, Inst Mol Virol, Munster, Germany
关键词
D O I
10.1182/blood-2006-09-047563
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Regulatory T cells play an essential role in the control of self-tolerance and processes of adaptive immunity. Tolerogenic IL-10-modulated human dendritic cells (IL-10DCs) induce anergic T cells with strong suppressive properties (iTregs) that inhibit the activation of effector T cells. In this study, we evaluated the interaction between cell-cycle regulation and intracellular signaling in these iTregs. Analysis of signal transduction events revealed a down-regulation of the mitogen-activated protein kinases (MAPKS) Jun N-terminal kinase (JNK) and a nonactivation of extracellular-signal-regulated kinase (ERK) in contrast to a marked activation of p38 MAPK and the p38 effector MAPK-activated protein kinases 2/3 (MAPKAP2/3). The elevated activation of p38 is critical for the induction and maintenance of anergy controlled by an increased expression of the cell-cycle inhibitor P27(Kip). Moreover, blocking experiments with the specific inhibitor SB203580 demonstrated that the regulatory function of iTregs is associated with an enhanced p38 MAPK activity. In contrast to other Treg populations, the suppressor function of iTregs is independent of IL-10. In conclusion, our data indicate that a cross-talk of cell-cycle regulation and p38-dependent signal transduction is required for the suppressor function of iTregs.
引用
收藏
页码:4351 / 4359
页数:9
相关论文
共 52 条
[1]   CD4+ regulatory T cells:: Mechanisms of induction and effector function [J].
Bacchetta, R ;
Gregori, S ;
Roncarolo, MG .
AUTOIMMUNITY REVIEWS, 2005, 4 (08) :491-496
[2]   Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients [J].
Banerjee, Devi K. ;
Dhodapkar, Madhav V. ;
Matayeva, Elyana ;
Steinman, Ralph M. ;
Dhodapkar, Kavita M. .
BLOOD, 2006, 108 (08) :2655-2661
[3]   Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2 [J].
Ben-Levy, R ;
Hooper, S ;
Wilson, R ;
Paterson, HF ;
Marshall, CJ .
CURRENT BIOLOGY, 1998, 8 (19) :1049-1057
[4]  
BHANDOOLA A, 1993, J IMMUNOL, V151, P2355
[5]   Bone marrow-derived dendritic cells reverse the anergic state of CD4+CD25+ T cells without reversing their suppressive function [J].
Brinster, C ;
Shevach, EM .
JOURNAL OF IMMUNOLOGY, 2005, 175 (11) :7332-7340
[6]   Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway [J].
Chen, CY ;
Del Gatto-Konczak, F ;
Wu, ZG ;
Karin, M .
SCIENCE, 1998, 280 (5371) :1945-1949
[7]  
Chen CY, 2000, GENE DEV, V14, P1236
[8]   The p38 mitogen-activated protein kinase pathway in activated and anergic Th1 cells [J].
DeSilva, DR ;
Jones, EA ;
Feeser, WS ;
Manos, EJ ;
Scherle, PA .
CELLULAR IMMUNOLOGY, 1997, 180 (02) :116-123
[9]   Activation of the p38 mitogen-activated protein kinase pathway arrests cell cycle progression and differentiation of immature thymocytes in vivo [J].
Diehl, NL ;
Enslen, H ;
Fortner, KA ;
Merritt, C ;
Stetson, N ;
Charland, C ;
Flavell, RA ;
Davis, RJ ;
Rincón, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (02) :321-334
[10]   The p38 mitogen-activated protein kinase regulates effector functions of primary human CD4 T cells [J].
Dodeller, F ;
Skapenko, A ;
Kalden, JR ;
Lipsky, PE ;
Schulze-Koops, H .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (12) :3631-3642